Search Results - "Luigi, Cavanna"
-
1
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature
Published in The oncologist (Dayton, Ohio) (01-12-2015)“…The burden of travel from a patient's residence to health care providers is an important issue that can influence access to diagnosis and treatment of cancer…”
Get full text
Journal Article -
2
COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
Published in Vaccines (Basel) (20-09-2021)“…Patients with cancer are among the most vulnerable groups of the COVID-19 pandemic, whereas vaccinations can represent a cornerstone in overcoming the pandemic…”
Get full text
Journal Article -
3
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)
Published in Future oncology (London, England) (01-07-2020)“…We describe cancer patients with coronavirus disease-2019 (COVID-19) infection treated at the Piacenza’s general hospital (north Italy). 25 cancer patients…”
Get full text
Journal Article -
4
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study
Published in Oncotarget (03-10-2017)“…In cancer patients, malnutrition is associated with treatment toxicity, complications, reduced physical functioning, and decreased survival. The Prevalence of…”
Get full text
Journal Article -
5
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
Published in British journal of cancer (07-07-2020)“…Background Despite sensitivity to first-line chemotherapy, most small-cell lung cancer (SCLC) patients relapse. In this setting, topotecan demonstrated modest…”
Get full text
Journal Article -
6
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
Published in Journal of clinical oncology (01-06-2012)“…This is a noncomparative, randomized, phase II trial of preoperative taxane-anthracycline in combination with trastuzumab, lapatinib, or combined trastuzumab…”
Get full text
Journal Article -
7
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
Published in Journal of clinical oncology (10-02-2016)“…The WHO guidelines on cancer pain management recommend a sequential three-step analgesic ladder. However, conclusive data are lacking as to whether moderate…”
Get full text
Journal Article -
8
Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy
Published in Supportive care in cancer (01-04-2022)“…Purpose Little is known about the real impact of the COVID-19 outbreak on the qualitative and quantitative fall-out on the management of cancer patients. Our…”
Get full text
Journal Article -
9
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Published in The lancet oncology (01-10-2009)“…Summary Background Clinical trials are needed to assess the clinical benefit of antithrombotic prophylaxis in patients with cancer who are receiving…”
Get full text
Journal Article -
10
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
Published in Journal of clinical oncology (01-04-2010)“…Single-agent gemcitabine became standard first-line treatment for advanced pancreatic cancer after demonstration of superiority compared with fluorouracil. The…”
Get full text
Journal Article -
11
Cancer Treatment Closer to the Patient Reduces Travel Burden, Time Toxicity, and Improves Patient Satisfaction, Results of 546 Consecutive Patients in a Northern Italian District
Published in Medicina (Kaunas, Lithuania) (01-12-2023)“…: The distance to cancer facilities may cause disparities by creating barriers to oncologic diagnosis and treatment, and travel burden may cause time and…”
Get full text
Journal Article -
12
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01-07-2022)“…Background EOX (epirubicin, oxaliplatin, and capecitabine) is one of the standard regimens for metastatic or locally advanced gastric cancer (GC). A new…”
Get full text
Journal Article -
13
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial
Published in Breast cancer research and treatment (01-05-2020)“…Purpose To evaluate the prognostic value of IGF-1R expression on circulating tumor cells (CTCs) in a prospective randomized clinical trial comparing…”
Get full text
Journal Article -
14
A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home
Published in Curēus (Palo Alto, CA) (25-10-2022)“…In the absence of evidenced-based guidelines for early home treatment of COVID-19, some Italian groups of volunteer physicians (both general practitioners…”
Get full text
Journal Article -
15
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study
Published in BMC cancer (24-08-2022)“…Background The non-inferiority of dexamethasone (DEX) on day 1, with or without low-dose DEX on days 2 and 3, combined with oral NEPA…”
Get full text
Journal Article -
16
Autoimmune Encephalitis following Checkpoint Inhibitor Therapy in a Patient with Metastatic Melanoma in Complete Remission
Published in Medicina (Kaunas, Lithuania) (01-05-2024)“…The use of immune checkpoint inhibitors (ICIs) in cancer is increasing. Their side effects are mainly due to the triggering of autoimmunity, which are mild or…”
Get full text
Journal Article -
17
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
Published in British journal of cancer (20-07-2021)Get full text
Journal Article -
18
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer
Published in Therapeutic advances in medical oncology (2021)“…Background: The aim of this study was to improve activity over single human epidermal growth factor receptor 2 (HER2)-blockade sequential neaodjuvant regimens…”
Get full text
Journal Article -
19
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)
Published in Scientific reports (23-01-2023)“…We demonstrated the non-inferiority of a dexamethasone (DEX)-sparing (single-dose) regimen with NEPA, a netupitant/palonosetron fixed combination, for…”
Get full text
Journal Article -
20
Targeted photoimmunotherapy for cancer
Published in Biomolecular Concepts (19-03-2022)“…Photodynamic therapy (PDT) is a clinically approved procedure that can exert a curative action against malignant cells. The treatment implies the…”
Get full text
Journal Article